Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

OLE HEALTH

UEI: NE2EJLJDXAR5CAGE: 499P3

OLE HEALTH is a federal contractor, registered under UEI NE2EJLJDXAR5 and CAGE code 499P3. It has been awarded $73,993,896 across 17 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services and Department Of Agriculture.

Contact Information

Registration and classification details

Registration

UEI Code

NE2EJLJDXAR5

CAGE Code

499P3

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621498All Other Outpatient Care Centers(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

OLE HEALTH specializes in providing comprehensive health services and support solutions, leveraging its expertise in outpatient and community-based care delivery. The company’s core capabilities center on clinical operations, patient coordination, and health program implementation, with a focus on d...

OLE HEALTH specializes in providing comprehensive health services and support solutions, leveraging its expertise in outpatient and community-based care delivery. The company’s core capabilities center on clinical operations, patient coordination, and health program implementation, with a focus on delivering accessible, high-quality care in non-acute settings. Technical expertise includes health information systems integration, care management workflows, and compliance with federal healthcare standards such as HIPAA and CMS reporting requirements. OLE HEALTH differentiates itself through its localized, community-responsive service model, emphasizing culturally competent care delivery and operational agility in underserved regions. The firm’s approach prioritizes sustainable health outcomes through integrated service design and stakeholder collaboration. Due to insufficient award data, specific agency relationships cannot be identified. The contractor’s past performance does not provide sufficient detail to characterize engagement patterns with federal departments or mission-critical programs. The primary NAICS code, 621498, classifies OLE HEALTH under “Other Outpatient Care Centers,” indicating its operational focus on ambulatory health services outside traditional hospital environments. This includes services such as behavioral health clinics, mobile health units, and preventive care centers. The company’s market positioning is aligned with expanding access to outpatient services, particularly in areas with limited infrastructure or provider shortages. OLE HEALTH is structured as an 8H entity, indicating it is a small business owned and controlled by a Native American individual or tribe. The company is headquartered in Napa, California, with operations likely focused on serving regional and tribal health initiatives. While no formal government certifications are listed, its 8H status provides eligibility for targeted contracting opportunities under the SBA’s 8(a) program and tribal set-aside authorities. Its geographic presence reflects a strategic alignment with rural and tribal healthcare access priorities.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$74.0M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with OLE HEALTH

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for OLE HEALTH

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in OLE HEALTH's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports the Small Business Technology Transfer (STTR) program, which provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development in partnership with non-profit research institutions. The program is designed to develop commercial products that align with the NIH mission to enhance health, lengthen life, and reduce illness and disability. Eligible SBCs must be for-profit entities located and operating primarily in the United States, be more than 50 percent owned and controlled by U.S. citizens or permanent residents, and have no more than 500 employees. The program is structured in multiple phases: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. NIH also offers Fast-Track applications to combine both phases and Direct to Phase II awards for projects that have already demonstrated feasibility. Funding limits vary by the participating NIH Institute or Center, with Phase I limits typically ranging from 400,000 to 700,000 dollars and Phase II limits reaching up to 3,000,000 dollars. Applications are evaluated based on scientific and technical merit, commercial potential, and the strength of the commercialization plan. Clinical trials are optional but subject to specific restrictions; certain institutes, such as NIAID and NIAMS, do not accept them under this NOFO. Projects involving clinical trials must include a regulatory plan and adhere to strict safety monitoring and registration requirements via ClinicalTrials.gov. Additionally, recipients must comply with cybersecurity incident reporting guidelines, notifying HHS agencies of any breaches within 48 hours. Applications must be submitted through Grants.gov and tracked via eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
Notice of Funding Opportunity PA-27-100 provides early-stage funding to United States small business concerns (SBCs) to conduct research and development necessary for the creation of commercial products that support the missions of the NIH, CDC, and FDA. The program is structured in multiple phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track grant applications. Funding limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated based on scientific and technical merit through a peer review system, focusing on significance and the suitability of the scientific and business environment. While clinical trials are generally permitted, certain institutes and centers, including all FDA components, do not accept them under this specific NOFO. Awardees must comply with strict administrative requirements, including maintaining active SAM registration, obtaining a Unique Entity Identifier, and adhering to cybersecurity incident reporting protocols that require notification of breaches within 48 hours. The deadline for response is April 6, 2027, and all applications must be submitted electronically.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) program, under solicitation PAR-27-098, provides later-stage research and development and technical assistance to help U.S. small business concerns transition NIH-funded projects from Phase II or Phase IIB Strategic Breakthrough awards toward full commercialization. The program supports activities such as clinical trials, IND/IDE-enabling studies, manufacturing scale-up, independent replication of key studies, and regulatory or intellectual property strategy. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the work. Eligible applicants must be U.S. small business concerns with no more than 500 employees and must maintain active registrations in SAM, including a CAGE code and Unique Entity Identifier. The maximum project period is three years, with budget ceilings varying by NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, significance, and commercial potential. Key requirements include a two-page regulatory plan, a CRP progress report, and adherence to strict cybersecurity incident reporting and clinical trial registration protocols. The solicitation expires on April 6, 2029.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details